Showing results (191-200 of 255) with videos related to

Sort By:
Pageof 26
Genome Research|December 10, 2008
HBEGF, SRA1, and IK: Three cosegregating genes as determinants of cardiomyopathyFrauke Friedrichs, Christian Zugck, Gerd-Jörg Rauch, et al.
Circulation Research|June 15, 2017
Identification and Functional Characterization of Hypoxia-Induced Endoplasmic Reticulum Stress Regulating lncRNA (HypERlnc) in PericytesFlorian C Bischoff, Astrid Werner, David John, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 25, 2021
Controlling my genome with my smartphone: first clinical experiences of the PROMISE systemAli Amr, Marc Hinderer, Lena Griebel, et al.
Basic Research in Cardiology|June 23, 2022
Reduction of A-to-I RNA editing in the failing human heart regulates formation of circular RNAsKaroline E Kokot, Jasmin M Kneuer, David John, et al.
Cardiovascular Research|March 30, 2019
Long noncoding RNA NEAT1 modulates immune cell functions and is suppressed in early onset myocardial infarction patientsMartina Gast, Bernhard H Rauch, Arash Haghikia, et al.
European Heart Journal|June 22, 2014
Silencing of CCR2 in myocarditisFlorian Leuschner, Gabriel Courties, Partha Dutta, et al.
Basic Research in Cardiology|March 9, 2022
Doxorubicin induces cardiotoxicity in a pluripotent stem cell model of aggressive B cell lymphoma cancer patientsLuis Peter Haupt, Sabine Rebs, Wiebke Maurer, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 11, 2022
Deep phenotyping of two preclinical mouse models and a cohort of RBM20 mutation carriers reveals no sex-dependent disease severity in <i>RBM20</i> cardiomyopathyDavid C Lennermann, Mark E Pepin, Markus Grosch, et al.
International Journal of Molecular Sciences|March 6, 2021
Energy Metabolites as Biomarkers in Ischemic and Dilated CardiomyopathyJan Haas, Karen S Frese, Farbod Sedaghat-Hamedani, et al.
American Heart Journal|September 14, 2025
Catheter-based left atrial appendage CLOSURE in patients with atrial fibrillation at high risk of stroke and bleeding as compared to best medical therapy: Rationale and design of the prospective randomized CLOSURE-AF trialUlf Landmesser, Carsten Skurk, Paulus Kirchhof, et al.
Pageof 26